Pharma Journalist -

Teva Pharmaceutical Industries Ltd. announced the launch of a generic version of Lialda (mesalamine) delayed-release tablets, 1.2 g, in the U.S. Mesalamine delayed-release tablets…
Read More...

Arrowhead Pharmaceuticals announced that it has dosed the first subjects in a Phase 1/2 clinical study of ARO-HBV, which is being developed as a potentially curative therapy for…
Read More...

Syngene International announced an R&D agreement with GSK. The multiyear agreement will focus on accelerating the discovery of new drug candidates using Syngene’s discovery services…
Read More...

LEATHERHEAD, UK 27th March 2018 – Smithers Rapra will be extending its popular Extractables and Leachables (E&L) conference series into China later this year. Taking place in…
Read More...

Sandoz announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for marketing authorization of…
Read More...

CutisPharma announced that it has been acquired by NovaQuest Capital Management. As a part of the transaction, Goldman Sachs Specialty Lending Group has provided financing to further…
Read More...

Novo Nordisk announced that the US Food and Drug Administration (FDA) approved updates to the prescribing information (PI) for Tresiba (insulin degludec injection) 100 U/mL, 200 U/mL to…
Read More...

Pfizer Inc. announced results from a Phase 4 study evaluating the efficacy and safety of CHANTIX/CHAMPIX (varenicline) for smoking cessation in nicotine dependent adolescents 12-19…
Read More...

Flex Pharma announced positive topline data for FLX-787 from its exploratory Phase 2 trial in MS patients with frequent muscle cramps/spasms and spasticity. “MS patients frequently…
Read More...

SetPoint Medical announced that it has launched a pilot trial for patients with drug refractory rheumatoid arthritis (RA) in the U.S. The multi-center study, “A Randomized Controlled…
Read More...